Screen 20shot 202014 08 07 20at 2018.07.28
Mint 20labs 20logo 20  20square

Mint Labs

Cloud platform to analyze & 3D-visualize brains to help find cures for CNS diseases.

  • Stage $500K in TTM Revenue
  • Industry Software
  • Location Boston, MA, US
  • Currency USD
  • Founded April 2013
  • Employees 13
  • Incorporation Type C-corp
  • Website mint-labs.com

Company Summary

Mint Labs provides a cloud-based neuroimaging platform with advanced data management and analysis tools in addition to state-of-the-art 3D touchless visualization capabilities to better understand the human brain and diseases of the central nervous system. We aim to ease research workflow and collaboration to accelerate the discovery and development of new therapies for neurological diseases and to build the biggest brain database in the world.

Team

  • From Macedonia, 32 years, Vesna is a neuroscientist and an entrepreneur. Expert in neuroimaging for neurodegenerative diseases. Intelligent and an excellent liaison between the research and the clinical worlds. She used to work at Harvard University and was a prestigious Marie Curie fellow, advancing imaging tools for the development of new therapies for Multiple Sclerosis.

  • A portuguese, 34 years old entrepreneur, software engineer and neuroscientist. Was awarded in 2014 the young innovator under 35 by MIT TR.
    He adds his scientific experience, acquired in The Netherlands, to international industrial IT experience. Presents creative solutions to complex problems.

  • Landon, 32 from the United States, balances the team with his 12 years of experience in finance, management, and sales. Having run 2 companies previously he has the experience to help the company grow quickly and efficiently.

Advisors

  • Default avatar
    Gary Robinson
    Pharma, Med-Tech advisor
    Unconfirmed
    9ad0a6cb ff0e 4d30 a151 41e93f8beb73
    New therapies for Neurological disorders
    Default avatar
    Walter Gilbert
    Unconfirmed

Previous Investors